Dacomitinib
About
Therapy type: Targeted therapy
Therapy strategy: EGFR inhibition
Mappings
NCI Thesaurus: Dacomitinib (ncit:C53398)
RxNorm: dacomitinib (rxcui:2058849, omop:35200803)
SNOMED: Dacomitinib (sctid:781492009, omop:36683569)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | EGFR Exon 19 (Deletion) | Non-Small Cell Lung Cancer | Dacomitinib | |
| FDA (1) | EGFR p.L858R | Non-Small Cell Lung Cancer | Dacomitinib | |
| EMA (1) HSE (1) | EGFR activating variants | Non-Small Cell Lung Cancer | Dacomitinib |